PURPOSE: To investigate associations among imaging traits observed on computed tomographic (CT) images, Classification of Ovarian Cancer (CLOVAR) gene signatures, and survival in women with high-grade serous ovarian cancer (HGSOC). MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant retrospective study of CT images obtained before cytoreductive surgery in 46 women with HGSOC, whose tumors were subjected to molecular analysis performed by the Cancer Genome Atlas Research Network. Two readers independently evaluated the CT features of the primary ovarian mass and sites of metastatic spread if present, including size, outline, and texture. Fisher exact test was used to examine the relationship between imaging traits and CLOVAR subtypes (CLOVAR differentiated, immunoreactive, mesenchymal, and proliferative). Kaplan-Meier and Cox proportional hazards regression survival analyses were performed. RESULTS: The presence of mesenteric infiltration and diffuse peritoneal involvement by tumor at CT were significantly associated with CLOVAR subtype (P = .002-.004 for reader 1 and P = .005-.012 for reader 2). Mesenteric infiltration at CT was associated with CLOVAR mesenchymal subtype. Patients with mesenteric infiltration had shorter median progression-free survival than patients without mesenteric involvement (14.7 months vs 25.6 months according to both readers; P = .019 for reader 1 and .015 for reader 2) and overall survival (49.0 vs 58.2 months; P = .014 [reader 1] and 50.0 vs 59.1 months; P = .015 [reader 2]). No other imaging features were significantly associated with CLOVAR subtype or survival. CONCLUSION: Specific CT imaging traits were associated with the CLOVAR subtypes and survival in patients with HGSOC.
PURPOSE: To investigate associations among imaging traits observed on computed tomographic (CT) images, Classification of Ovarian Cancer (CLOVAR) gene signatures, and survival in women with high-grade serous ovarian cancer (HGSOC). MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant retrospective study of CT images obtained before cytoreductive surgery in 46 women with HGSOC, whose tumors were subjected to molecular analysis performed by the Cancer Genome Atlas Research Network. Two readers independently evaluated the CT features of the primary ovarian mass and sites of metastatic spread if present, including size, outline, and texture. Fisher exact test was used to examine the relationship between imaging traits and CLOVAR subtypes (CLOVAR differentiated, immunoreactive, mesenchymal, and proliferative). Kaplan-Meier and Cox proportional hazards regression survival analyses were performed. RESULTS: The presence of mesenteric infiltration and diffuse peritoneal involvement by tumor at CT were significantly associated with CLOVAR subtype (P = .002-.004 for reader 1 and P = .005-.012 for reader 2). Mesenteric infiltration at CT was associated with CLOVAR mesenchymal subtype. Patients with mesenteric infiltration had shorter median progression-free survival than patients without mesenteric involvement (14.7 months vs 25.6 months according to both readers; P = .019 for reader 1 and .015 for reader 2) and overall survival (49.0 vs 58.2 months; P = .014 [reader 1] and 50.0 vs 59.1 months; P = .015 [reader 2]). No other imaging features were significantly associated with CLOVAR subtype or survival. CONCLUSION: Specific CT imaging traits were associated with the CLOVAR subtypes and survival in patients with HGSOC.
Authors: Dimitrios Spentzos; Douglas A Levine; Marco F Ramoni; Marie Joseph; Xuesong Gu; Jeff Boyd; Towia A Libermann; Stephen A Cannistra Journal: J Clin Oncol Date: 2004-10-25 Impact factor: 44.544
Authors: J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton Journal: Proc Natl Acad Sci U S A Date: 2001-01-30 Impact factor: 11.205
Authors: C Blake Gilks; Barbara C Vanderhyden; Shirley Zhu; Matt van de Rijn; Teri A Longacre Journal: Gynecol Oncol Date: 2005-03 Impact factor: 5.482
Authors: Dirk De Ruysscher; Hoda Sharifi; Gilles Defraene; Sarah L Kerns; Melissa Christiaens; Kim De Ruyck; Stéphanie Peeters; Johan Vansteenkiste; Robert Jeraj; Frank Van Den Heuvel; Wouter van Elmpt Journal: Acta Oncol Date: 2013-08-19 Impact factor: 4.089
Authors: Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh Journal: Clin Cancer Res Date: 2005-03-15 Impact factor: 12.531
Authors: Marci E Schaner; Douglas T Ross; Giuseppe Ciaravino; Therese Sorlie; Olga Troyanskaya; Maximilian Diehn; Yan C Wang; George E Duran; Thomas L Sikic; Sandra Caldeira; Hanne Skomedal; I-Ping Tu; Tina Hernandez-Boussard; Steven W Johnson; Peter J O'Dwyer; Michael J Fero; Gunnar B Kristensen; Anne-Lise Borresen-Dale; Trevor Hastie; Robert Tibshirani; Matt van de Rijn; Nelson N Teng; Teri A Longacre; David Botstein; Patrick O Brown; Branimir I Sikic Journal: Mol Biol Cell Date: 2003-09-05 Impact factor: 4.138
Authors: Donald R Schwartz; Sharon L R Kardia; Kerby A Shedden; Rork Kuick; George Michailidis; Jeremy M G Taylor; David E Misek; Rong Wu; Yali Zhai; Danielle M Darrah; Heather Reed; Lora H Ellenson; Thomas J Giordano; Eric R Fearon; Samir M Hanash; Kathleen R Cho Journal: Cancer Res Date: 2002-08-15 Impact factor: 12.701
Authors: Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding Journal: Nature Date: 2013-10-17 Impact factor: 49.962
Authors: Stephanie Nougaret; Yulia Lakhman; Mithat Gönen; Debra A Goldman; Maura Miccò; Melvin D'Anastasi; Sarah A Johnson; Krishna Juluru; Angela G Arnold; Ramon E Sosa; Robert A Soslow; Hebert Alberto Vargas; Hedvig Hricak; Noah D Kauff; Evis Sala Journal: Radiology Date: 2017-06-16 Impact factor: 11.105
Authors: Hebert Alberto Vargas; Harini Veeraraghavan; Maura Micco; Stephanie Nougaret; Yulia Lakhman; Andreas A Meier; Ramon Sosa; Robert A Soslow; Douglas A Levine; Britta Weigelt; Carol Aghajanian; Hedvig Hricak; Joseph Deasy; Alexandra Snyder; Evis Sala Journal: Eur Radiol Date: 2017-03-13 Impact factor: 5.315
Authors: Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris Journal: J Magn Reson Imaging Date: 2017-11-02 Impact factor: 4.813
Authors: Hebert Alberto Vargas; Erich P Huang; Yulia Lakhman; Joseph E Ippolito; Priya Bhosale; Vincent Mellnick; Atul B Shinagare; Maria Anello; Justin Kirby; Brenda Fevrier-Sullivan; John Freymann; C Carl Jaffe; Evis Sala Journal: Radiology Date: 2017-06-22 Impact factor: 11.105
Authors: Yaser R Hussein; Jennifer A Ducie; Angela G Arnold; Noah D Kauff; Hebert A Vargas-Alvarez; Evis Sala; Douglas A Levine; Robert A Soslow Journal: Am J Surg Pathol Date: 2016-03 Impact factor: 6.394